MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive
Angiogenesis Research Studies have examined GHK-Cus pro-angiogenic properties in pre-clinical wound and tissue repair models, with research documenting its effects on endothelial cell behaviour, vascular endothelial growth factor (VEGF) signalling, and new blood vessel formation reflecting the critical role of vascular supply in effective tissue repair and regeneration
We demonstrate mechanistically the need for increased mitochondrial function, facilitated by mTORPGC1-mediated mitochondrial biogenesis, to support rebalancing of pyrimidines via UCK2 to support cellular survival in the face of continued 5FU treatment
How to Choose the Best Glutathione IV Therapy When considering glutathione IV therapy, its important to choose a high-quality clinic
Brand-name products like Ozempic and Wegovy come as pre-filled pens and don't require reconstitution